Sunday, May 21, 2006

The pharmaceutical pipeline is filled with promise

Doctors are close to adding one more powerful ingredient to their antiviral recipe against AIDS, Miraviroc Researchers at Pfizer have developed the first in a new class of compounds that would prevent HIV from entering or infecting a healthy cell. So far, the medications that have saved millions of AIDS patients around the world have thwarted HIV at the end of its reproductive cycle; Pfiezer's compound, a once a day pill called Miraviroc, targets the beginning of the disease process. Now in the last stage of being tested in patients, the compound, in combination with other anti-HIV drugs, could become a significant roadblock in preventing HIV infections from mushrooming into full-blown cases of AIDS.

http://www.chartsbank.com/PipelineList.aspx

No comments: